·
2 MIN READ

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
·
8 MIN READ

Dec. 2, 2022: National Advocacy Update

Moving from policy to action: Fighting the nation’s drug overdose and death epidemic, and more in the latest National Advocacy Update.

Advocacy Update
·
14 MIN READ

Nov. 11, 2022: National Advocacy Update

Bipartisan House letter coincides with launch of APM coalition and more in the latest National Advocacy Update.

Advocacy Update
Narcan kit
·
3 MIN READ

FDA naloxone guidance helps harm-reduction groups’ work to save lives

Learn how new clarity from the FDA on burdensome requirements for bulk purchase of naloxone aid underserved communities.

Overdose Epidemic
·
7 MIN READ

Sept. 30, 2022: National Advocacy Update

Physicians’ unified message to Congress: Reform Medicare pay now in the latest National Advocacy Update.

Advocacy Update
·
2 MIN READ

Sept. 16, 2022: Advocacy Update spotlight on 2022 Overdose report

AMA 2022 Overdose Report shows worsening epidemic, need for all-hands approach and more in the latest Advocacy Update spotlight.

Advocacy Update
Two hands reaching out
·
4 MIN READ

Barriers to care cause drug overdose and death epidemic to deepen

Illicit drugs are fueling the overdose epidemic. A new AMA report makes clear how physicians, payers, policymakers and others can help save lives.

Overdose Epidemic
·
3 MIN READ

Trends on overdose deaths require specific actions, all-hands approach

With a report issued today detailing the horrific toll of the nation’s overdose and death epidemic, the AMA calls for an all-hands approach to help save lives.

Press Releases
·
9 MIN READ

Sept. 2, 2022: National Advocacy Update

International Overdose Awareness Day underscores urgent need for change and more in the latest National Advocacy Update.

Advocacy Update